Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07223242 · ClinicalTrials.gov registry record · Phase 2

Tailored Exercise Training Study Among Adults With HFpEF

A Phase 2 study of HFpEF - Heart Failure With Preserved Ejection Fraction and Diabetic Cardiomyopathies, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
Phase 2
Development phase
120
Enrollment target
1
Study location

NCT07223242 is a Phase 2 study of HFpEF - Heart Failure With Preserved Ejection Fraction and Diabetic Cardiomyopathies that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 120 participants, below the 9,861-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07223242, a Phase 2 study of HFpEF - Heart Failure With Preserved Ejection Fraction and Diabetic Cardiomyopathies, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
Phase 2
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

Heart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the treatment of HFpEF. Exercise intolerance (EI) is the cardinal symptom of HFpEF, which manifests as dyspnea and fatigue. EI leads to functional deconditioning and reduced quality of life (QOL), both of which elevate risk of death and hospitalization in patients with HFpEF. Supervised exercised training is associated with improvements in exercise capacity and QOL in adults with HFpEF. However, supervised exercise has not been widely utilized for the treatment of HFpEF due to logistical and fiscal barriers. This study will investigate the effects of a remote exercise training intervention on exercise capacity and skeletal muscle composition in patients with HFpEF, or those at risk for it. In addition, it will compare four different lifestyle interventions for their effects on exercise capacity.

Interventions

  • BEHAVIORAL Resistance training
  • BEHAVIORAL Moderate-intensity continuous training (MCT)
  • DRUG Weight loss

Study Locations (1)

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2025-02-18
Est. Completion 2026-12-30
Phase Phase 2

What the Registry Record Tells You About NCT07223242

The ClinicalTrials.gov registry entry for NCT07223242 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,861-participant average among 6 other HFpEF - Heart Failure With Preserved Ejection Fraction trials with a reported enrollment target (99% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with HFpEF - Heart Failure With Preserved Ejection Fraction appearing as the primary indexed condition, and to 3 interventions - of which Resistance training is the first listed.

NCT07223242 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT07223242 about?

NCT07223242 is a clinical study titled "Tailored Exercise Training Study Among Adults With HFpEF". Heart failure with preserved ejection fraction (HFpEF) is associated with a high morbidity and mortality burden. There are limited pharmacological options available for the treatment of HFpEF. Exercise intolerance (EI) is the cardinal symptom of HFpEF, which manifests as dyspnea and fatigue. EI lead...

What is the current status of trial NCT07223242?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2025-02-18. Estimated completion is 2026-12-30.

What conditions does trial NCT07223242 study?

This clinical trial studies the following conditions: HFpEF - Heart Failure With Preserved Ejection Fraction, Diabetic Cardiomyopathies.

What interventions are being tested in trial NCT07223242?

The interventions under investigation include: Resistance training (BEHAVIORAL), Moderate-intensity continuous training (MCT) (BEHAVIORAL), Weight loss (DRUG).

Who is sponsoring clinical trial NCT07223242?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07223242 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HFpEF - Heart Failure With Preserved Ejection Fraction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.